Ralpancizumab Antibody
Ralpancizumab is a selective PCSK9 inhibitor with research potential for hemorrhagic stroke. It is utilized in biochemical and neurological research fields to study lipid metabolism and neuroprotection in relevant in vitro and in vivo experimental models.
Product Specifications
Target
Others
Clonality
Monoclonal
Conjugation
Unconjugated
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6122812-01 0.1 mL
CD5 (CD5 antigen (p56 62), LEU1, Ly12, LyA, Lymphocyte antigen T1/Leu-1, Lymphocyte glycoprotein T1/Leu1, T-cell surface glycoprotein CD5) (PE)
Sign In for Pricing
View Details MBS6122812-02 5x 0.1 mL
CD5 (CD5 antigen (p56 62), LEU1, Ly12, LyA, Lymphocyte antigen T1/Leu-1, Lymphocyte glycoprotein T1/Leu1, T-cell surface glycoprotein CD5) (PE)
Sign In for Pricing
View Details 
MBS2034413-01 0.01 mg
Recombinant Phospholipid Scramblase 4 (PLSCR4)
Sign In for Pricing
View Details